Skip to content
OpenCapital
Get started

AMN Healthcare AMN Cash, Cash Equivalents, And Restricted Cash, Cash Equivalents, and Investments

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Cash & equivalents$595.0M+528%
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.25B+49.8%
Enterprise value$1.44B-11.9%
P/S0.4×+0.1×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept amn:CashCashEquivalentsAndRestrictedCashCashEquivalentsAndInvestments.

The official record: AMN Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's cash, cash equivalents, and restricted cash, cash equivalents, and investments.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's cash, cash equivalents, and restricted cash, cash equivalents, and investments?
AMN Healthcare (AMN) reported cash, cash equivalents, and restricted cash, cash equivalents, and investments of $629.08M in Q1 2026.
How has AMN Healthcare's cash, cash equivalents, and restricted cash, cash equivalents, and investments changed year-over-year?
AMN Healthcare's cash, cash equivalents, and restricted cash, cash equivalents, and investments increased by 435.6% year-over-year, from $117.45M to $629.08M.
What is the long-term trend for AMN Healthcare's cash, cash equivalents, and restricted cash, cash equivalents, and investments?
Over 3 years (2022 to 2025), AMN Healthcare's cash, cash equivalents, and restricted cash, cash equivalents, and investments has grown at a -14.7% compound annual growth rate (CAGR), from $162.97M to $101.21M.